RxDoctor Payments Data

Peter Anderson

Family · Los Angeles, CANPI 1821152380

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $3,377 of the $5,497 with a category attached, or 61.4%. Napo Pharmaceuticals Inc accounts for 61.7% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2021 at $3,910 and has fallen 84.0% since, to $625 in 2023. Among family clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,497in general payments, 2019–2025

Across 126 payments — averaging $43.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Napo Pharmaceuticals Inc$3K
  • Viiv Healthcare Company$486
  • Gilead$351
  • AbbVie$340
  • Johnson & Johnson$188
  • Antares Pharma, Inc.$111
  • plus $629 from 18 others

What the payments were for

  • Speaking & faculty fees$3,37761%
  • Food & beverage$2,12139%

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,497 in reported general payments places this provider in the 95th percentile of 10,634 family providers in California.

See all family providers in California →

Other family in Los Angeles

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →